Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

January’s top stories: Carlyle’s $4.15bn acquistion, Edwards Lifesciences’ approval

The Carlyle Group agreed to buy Johnson & Johnson's Ortho-Clinical Diagnostics (OCD) business for $4.15bn, while Edwards Lifesciences obtained CE Mark approval for Sapien 3 transcatheter aortic valve. wraps-up the key headlines from January 2014.

Go Top